• Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
  • Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
  • Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
  • Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
  • Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
  • Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder

Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder

Powder: Yes
Customized: Non-Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Solid
Purity: >99%
Samples:
US$ 210/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
HNB-271
Transport Package
Aluminium Foil Bag, Cardboard Drum
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
5000kg/Month

Product Description

Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder

Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder


Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
Product name Flavoxate hydrochloride 
Cas No. 3717-88-2
Molecular Formula C24H26ClNO4
Appearance White powder
 

Flavoxate Hydrochloride(DW-61 Hydrochloride) is a muscarinic AChR antagonist used in various urinary syndromes and as an antispasmodic.Target: mAChRFlavoxate displaces [3H]nitrendipine on the Ca2+ channels binding sites with IC50 of 254 μM [1]. Flavoxate (>10 μM) suppresses carbachol-induced contractions in isolated rat detrusor strips with pD value of 4.55. Flavoxate (>10 μM) suppresses Ca2+-induced contractions in isolated rat detrusor strips with pIC50 value of 4.92 [2]. Flavoxate (0.01 μM ?10 μM) inhibits CAMP formation in a concentration-dependent manner in membranes from the rat striatum and cerebral cortex, an action which is completely abolished by pretreating the membranes with pertussis toxin (PTX).

Medication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride PowderMedication for Urinary System CAS 3717-88-2 Diuretic Flavoxate Hydrochloride Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now